Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

UK In Silico Regulatory Innovation Task Force

UK In Silico Regulatory Innovation Task Force

BACK

UK In Silico Regulatory Innovation Task Force

Mission: Nurture a cross-sector UK in silico trials community for regulatory science & innovation to produce evidence and harmonize standards in the UK accelerating in silico adoption in regulations

The UK In Silico Regulatory Innovation Task Force is making waves in the field of medical research. Led by Alejandro Frangi (University of Manchester) and David Flynn (Boston Scientific), this group is dedicated to nurturing a collaborative environment that advances in silico clinical trials and paves the way for their wider adoption.

Their efforts hold the potential to revolutionise medical research, leading to faster development of life-saving treatments for patients worldwide.

The Task Force champions UK standardisation efforts through organisations like BSI (British Standards Institution) and fosters collaboration with international counterparts like the FDA (US Food and Drug Administration) and EMA (European Medicines Agency). This collaborative effort will ensure consistency and facilitate the global acceptance of in silico trials.

Goals

  • Facilitating intra-UK and UK-international dialogue promoting adoption of in silico regulatory science and innovation.
  • Develop the evidence for in silico trials and predictive medicine as a response to the TIGR Report.
  • Actively engage with UK Government, Trade Associations, Standardisation Bodies, Regulators & Policy makers.
  • Map out the economic impact and supply chain for the UK economy of in silico regulatory science and innovation.
  • Promote UK standardisation efforts (e.g., via BSI etc.) with international standardisation initiatives.
  • Promote collaboration between MHRA, FDA and EMA around medical products regulatory science and innovation

Alejandro Frangi

Alejandro Frangi

Co-chair of the UK In Silico Regulatory Innovation Task Force

University of Manchester

READ BIO
David Flynn

David Flynn

Co-chair of the UK In Silico Regulatory Innovation Task Force

Fellow CM&S, Boston Scientific

READ BIO

NEWS

News Avicenna Day (AAD) 2024 Recordings Now Available

Avicenna Day (AAD) 2024 Recordings Now Available

Did you enjoy AAD 2024 and want to rewatch presentations from world-class thought leaders? Or did you miss the event? This news is for you!

News BioTechX event, Basel

BioTechX event, Basel

The BioTechX event in Basel provided an excellent opportunity for the Avicenna Alliance to engage with key pharmaceutical players and discuss the growing role of in silico methods in drug discovery and development, drug delivery and manufacturing.

News Nobel Prize for in silico modelling

Nobel Prize for in silico modelling

Congratulations to the winners of the 2024 Nobel Prize in Chemistry! This year's prestigious award honours revolutionary advancements in computational modelling, specifically in the study and design of proteins—the fundamental components of life.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry